These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23847990)

  • 1. [The cutting-edge of medicine; pathogenesis and treatment of systemic sclerosis].
    Sato S
    Nihon Naika Gakkai Zasshi; 2013 May; 102(5):1226-32. PubMed ID: 23847990
    [No Abstract]   [Full Text] [Related]  

  • 2. How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis?
    Meyer O
    Clin Rheumatol; 1998; 17(3):179-80. PubMed ID: 9694047
    [No Abstract]   [Full Text] [Related]  

  • 3. [An update on systemic sclerosis].
    Kowal-Bielecka O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies in systemic sclerosis].
    Genth E; Mierau R
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1758-60. PubMed ID: 22933201
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical picture and therapy of progressive systemic scleroderma].
    Sönnichsen N; Brenke A; Witt C
    Dtsch Med Wochenschr; 1992 Mar; 117(11):427-31. PubMed ID: 1544345
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Very early and early systemic sclerosis: An update].
    Michaud M; Catros F; Ancellin S; Gaches F
    Rev Med Interne; 2019 Aug; 40(8):517-522. PubMed ID: 30981561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis: a critical digest of the recent literature.
    Barsotti S; Stagnaro C; Della Rossa A
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S3-14. PubMed ID: 26243174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scleroderma].
    Hasegawa M; Takehara K; Sato S
    Nihon Rinsho; 2005 May; 63 Suppl 5():295-9. PubMed ID: 15954365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laboratory diagnostics for systemic sclerosis].
    Mierau R; Roers A; Genth E
    Z Rheumatol; 2007 May; 66(3):206, 208-11. PubMed ID: 17354003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy for systemic sclerosis].
    Umehara H; Tanaka M; Masaki Y; Fukushima T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2165-70. PubMed ID: 18044151
    [No Abstract]   [Full Text] [Related]  

  • 13. One year in review 2016: systemic sclerosis.
    Barsotti S; Stagnaro C; d'Ascanio A; Della Rossa A
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):3-13. PubMed ID: 27463613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma and related conditions.
    Mitchell H; Bolster MB; LeRoy EC
    Med Clin North Am; 1997 Jan; 81(1):129-49. PubMed ID: 9012758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis: commonly asked questions by rheumatologists.
    Young A; Khanna D
    J Clin Rheumatol; 2015 Apr; 21(3):149-55. PubMed ID: 25807095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial lung manifestations in systemic scleroderma. Correlation between alveolitis, autoantibodies and clinical manifestations].
    Witt C; Hiepe F; Brenke A; Romberg B; Apostoloff E
    Z Arztl Fortbild (Jena); 1994 Nov; 88(11):867-71. PubMed ID: 7839707
    [No Abstract]   [Full Text] [Related]  

  • 19. Scleroderma - new aspects in pathogenesis and treatment.
    Balbir-Gurman A; Braun-Moscovici Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):13-24. PubMed ID: 22424190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.